Corcept Therapeutics | CORT - Ordinary Share Capital


Corcept Therapeutics reported $105.97M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Acadia Pharmaceuticals USD 169.18M 470K Dec/2025
Alaunos Therapeutics USD 2.21M 131K Sep/2025
ANI Pharmaceuticals USD 22.49M 760K Dec/2025
Ardelyx USD 244.35M 1.38M Dec/2025
Assertio Holdings USD 9K 0 Dec/2023
Aurora Cannabis CAD 56.71M 134.13K Dec/2025
BioMarin Pharmaceutical USD 192.3M 201K Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Canopy Growth CAD 368.28M 35.9M Dec/2025
Corcept Therapeutics USD 105.97M 842K Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Esperion Therapeutics USD 245.22M 39.79M Dec/2025
J&J USD 2.41B 584K Sep/2025
Knight Therapeutics CAD 99.68M 24.66K Sep/2025
Lexicon Pharmaceuticals USD 363.47M 67K Dec/2025
Merck USD 2.49B 15.79M Sep/2025
Nektar Therapeutics USD 20.38M 20.36M Dec/2025
Novartis USD 1.91B 10.64M Dec/2025
Novartis USD 1.91B 10.64M Dec/2025
Omeros USD 611K 17K Dec/2023
Pacira USD 41.12M 1.85M Dec/2025
Pfizer USD 5.69B 1000K Sep/2025
Supernus Pharmaceuticals USD 57.12M 1000K Sep/2025
TG Therapeutics USD 155.21M 2.81M Sep/2025